Skip to main content
Clinical Trials/NCT03331406
NCT03331406
Completed
Not Applicable

A Pilot Study of Physical Activity in Older Adults With Metastatic Gastrointestinal Cancer

Dana-Farber Cancer Institute1 site in 1 country20 target enrollmentDecember 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Metastatic Gastrointestinal Cancer
Sponsor
Dana-Farber Cancer Institute
Enrollment
20
Locations
1
Primary Endpoint
Rate of Accrual
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This research study is evaluating the ability for people with metastatic gastrointestinal cancer to participate in a physical activity program.

Detailed Description

The physical activity program is 12-weeks in length, and includes moderate-intensity aerobic, strength, flexibility, and balance training. * The goal of the aerobic training is to complete 150 minutes per week of brisk walking. * The goals of the strength, flexibility, and balance training are to engage in these activities twice per week.

Registry
clinicaltrials.gov
Start Date
December 1, 2017
End Date
January 22, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jeffrey A. Meyerhardt, MD

Prinicipal Investigator

Dana-Farber Cancer Institute

Eligibility Criteria

Inclusion Criteria

  • Start of trial:
  • A three-month of strict inclusion criteria (Phase 1).
  • At the end of three-months, if at least six participants have not been accrued, inclusion criteria will be expanded for a second three-month recruitment phase (Phase 2).
  • At the end of six-months, an average of two patients per month has not been accrued, a further expand inclusion criteria (Phase 3).
  • Phase 1 (most strict) Eligibility criteria include:
  • Voluntary, signed informed consent;
  • Diagnosis of histologically-confirmed esophageal, gastric, pancreatic, or colorectal that is metastatic or locally-advanced (unresectable);
  • First-line cytotoxic chemotherapy started within four-weeks of enrollment (patients can have reviewed prior adjuvant therapy if completed ≥6 months prior to start of first line chemotherapy for metastatic disease);
  • Age greater than 65 years;
  • Baseline weight-bearing physical activity less than 150 min∙wk-1 using the Paffenbarger physical activity questionnaire;

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Rate of Accrual

Time Frame: 12 months

Recruit 20 patients within 12 months

Number of participants that adhered to physical activity program

Time Frame: 12 Weeks

Demonstrate that at least 50% of patients adhered to at least 50% of the prescribed physical activity program.

Secondary Outcomes

  • Rate of Retention(12 Weeks)
  • Number of participants with adverse events(12 Weeks)
  • Number of participants that complete assessment procedures(12 Weeks)

Study Sites (1)

Loading locations...

Similar Trials